CorFigo: Funding, Investors & Team (Sep 2026)
CorFigo is a medical device company that develops a cryo-ablation device for the treatment of cardiac arrythmias. The company's device is delivered and positioned adjacent to the heart for minimally invasive ablation procedures and is intended to ablate generally large contiguous areas of cardiac tissue, such as atrial and ventricular tissue, with each individual application, enabling physicians to fix hearts that are not working properly, using creativity and technology. The HeartPad is a device intended for the ablation of cardiac tissue from an epicardial (outer surface of the heart) location, while simultaneously protecting adjacent structures from unintentional ablation injury. Designed for minimally invasive ablation, our proprietary technology utilizes potent cryothermal energy coupled with a sophisticated delivery system. The intended result of the HeartPad system’s unique and innovative design is the efficient and safe ablation of broad areas of cardiac tissue. CorFigo was founded in 2015 and is headquartered in Montclair, New Jersey, United States.
CorFigo has raised $2.4M across 1 funding round on record, the most recent an undisclosed round of $2.4M announced in Jan 2026.
That round is below the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.
CorFigo Company Profile and Key Stats
Latest funding round on record: Jan 2026.
CorFigo Funding Rounds
CorFigo Founders and Leadership Team
Contact details for the CorFigo team: 1 of 1 has an email address on file.
Start 14-day free trial →CorFigo Funding Compared to Other Health Care Startups
CorFigo's latest round of $2.4M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CorFigo in Health Care and Montclair
Companies Similar to CorFigo
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Thyme Care is an oncology solution that integrates patients and providers, working with health plans to…
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
CorFigo Funding FAQs
What does CorFigo do?
CorFigo is a medical device company that develops a cryo-ablation device for the treatment of cardiac arrythmias. The company's device is delivered and positioned adjacent to the heart for minimally invasive ablation procedures and is intended to ablate generally large contiguous areas of cardiac tissue, such as atrial and ventricular tissue, with each individual application, enabling physicians to fix hearts that are not working properly, using creativity and technology. The HeartPad is a device intended for the ablation of cardiac tissue from an epicardial (outer surface of the heart) location, while simultaneously protecting adjacent structures from unintentional ablation injury. Designed for minimally invasive ablation, our proprietary technology utilizes potent cryothermal energy coupled with a sophisticated delivery system. The intended result of the HeartPad system’s unique and innovative design is the efficient and safe ablation of broad areas of cardiac tissue. CorFigo was founded in 2015 and is headquartered in Montclair, New Jersey, United States.
How much funding has CorFigo raised?
CorFigo has raised $2.4M across 1 round on record. The most recent is an undisclosed round of $2.4M announced in Jan 2026.
When did CorFigo last raise funding?
CorFigo's most recent funding round on record is an undisclosed round of $2.4M, announced in Jan 2026.
Who founded CorFigo?
FundedIQ lists Deron Siddons (Founder) at CorFigo.
Where is CorFigo headquartered?
CorFigo is based in Montclair, New Jersey, United States.
How many employees does CorFigo have?
CorFigo is in the 1-10 employee band.
How does CorFigo's funding compare to other Health Care startups?
CorFigo's latest round of $2.4M is below the $4.8M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's CorFigo Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CorFigo is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.